It is worth mentioning that progerin has also been used to assist in modelling pathological phenotypes of late‐onset Parkinson's disease in human iPSC‐derived neurons (Miller et al., 2013), where expression of progerin in PD iPSC‐derived dopamine neurons induced ageing‐related markers and disease phenotypes, such as dendrite degeneration, Lewy‐body‐precursor inclusions and dysregulated protein degradation mechanisms. This evidence concerns the gene LMNA and Parkinson disease.